Cargando…

Peptide Drug Conjugates and Their Role in Cancer Therapy

Drug conjugates have become a significant focus of research in the field of targeted medicine for cancer treatments. Peptide-drug conjugates (PDCs), a subset of drug conjugates, are composed of carrier peptides ranging from 5 to 30 amino acid residues, toxic payloads, and linkers that connect the pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heh, Ethan, Allen, Jesse, Ramirez, Fabiola, Lovasz, Daniel, Fernandez, Lorena, Hogg, Tanis, Riva, Hannah, Holland, Nathan, Chacon, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820985/ https://www.ncbi.nlm.nih.gov/pubmed/36614268 http://dx.doi.org/10.3390/ijms24010829

Ejemplares similares

The Identification and Clinical Applications of Mutated Antigens in the Era of Immunotherapy
por: Kye, Yae, et al.
Publicado: (2022)

Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
por: Hoppenz, Paul, et al.
Publicado: (2020)

Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment
por: Ramirez, Fabiola, et al.
Publicado: (2023)

Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
por: Wu, Mo, et al.
Publicado: (2022)

Closing the digital divide: Developing a platform to conduct training, outreach, and education for employment skills
por: Johnson, Sarah, et al.
Publicado: (2023)

Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate
por: Puthenveetil, Sujiet, et al.
Publicado: (2017)

Research advances in peptide‒drug conjugates
por: Gong, Liming, et al.
Publicado: (2023)

Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy
por: Lindberg, Jakob, et al.
Publicado: (2021)

Molecular Engineering of Peptide–Drug Conjugates for Therapeutics
por: Fang, Yu, et al.
Publicado: (2022)

Are peptide conjugates the golden therapy against obesity?
por: Brandt, S J, et al.
Publicado: (2018)

NGR-peptide−drug conjugates with dual targeting properties
por: Enyedi, Kata Nóra, et al.
Publicado: (2017)

Lysosomal-Cleavable Peptide Linkers in Antibody–Drug Conjugates
por: Balamkundu, Seetharamsing, et al.
Publicado: (2023)

Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates
por: Gomena, Jacopo, et al.
Publicado: (2023)

A Rare Case of Herpes Simplex Virus and Cytomegalovirus Dual Infection Inducing Unremitting Ulcerative Colitis
por: Hock, Rivers A, et al.
Publicado: (2023)

Photodynamic therapy by conjugation of cell-penetrating peptide with fluorochrome
por: Park, Chul-Kyu, et al.
Publicado: (2017)

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma
por: Mateos, María-Victoria, et al.
Publicado: (2020)

ConjuPepDB: a database of peptide–drug conjugates
por: Balogh, Balázs, et al.
Publicado: (2020)

Peptide-Drug Conjugates: A New Hope for Cancer Management
por: Chavda, Vivek P., et al.
Publicado: (2022)

Molecular Dynamics Simulations of Drug-Conjugated Cell-Penetrating Peptides
por: Ivánczi, Márton, et al.
Publicado: (2023)

Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice
por: Janthur, Wolf-Dieter, et al.
Publicado: (2012)

Antibody–Drug Conjugates for Cancer Therapy
por: Parslow, Adam C., et al.
Publicado: (2016)

Antibody–Drug Conjugates for Cancer Therapy
por: Hafeez, Umbreen, et al.
Publicado: (2020)

Development of novel bone targeting peptide–drug conjugate of 13-aminomethyl-15-thiomatrine for osteoporosis therapy
por: Su, Jia, et al.
Publicado: (2021)

Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
por: Fu, Chen, et al.
Publicado: (2023)

Comparing Variants of the Cell-Penetrating Peptide sC18 to Design Peptide-Drug Conjugates
por: Grabeck, Joshua, et al.
Publicado: (2022)

On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
por: Vrettos, Eirinaios I, et al.
Publicado: (2018)

Antibody–Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome–Disruptive Peptide
por: Knewtson, Kelsey E., et al.
Publicado: (2019)

Insights into the Membranolytic Activity of Antimalarial Drug-Cell Penetrating Peptide Conjugates
por: Aguiar, Luísa, et al.
Publicado: (2020)

Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy
por: Liu, Qian, et al.
Publicado: (2018)

Gemcitabine Peptide-Based Conjugates and Their Application in Targeted Tumor Therapy
por: Hawryłkiewicz, Aleksandra, et al.
Publicado: (2021)

Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer
por: Gaurav, Isha, et al.
Publicado: (2021)

A Novel Homodimer Peptide–Drug Conjugate Improves the Efficacy of HER2-Positive Breast Cancer Therapy
por: Liu, Shurong, et al.
Publicado: (2023)

Biocatalysts Based on Peptide and Peptide Conjugate Nanostructures
por: Hamley, Ian W.
Publicado: (2021)

Lectin drug conjugate therapy for colorectal cancer
por: Kitaguchi, Daichi, et al.
Publicado: (2020)

Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatology
por: Esnault, Clara, et al.
Publicado: (2022)

Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells
por: Kalimuthu, Kalishwaralal, et al.
Publicado: (2018)

Peptide Conjugates for Biological Applications
Publicado: (2017)

Antimicrobial Peptide–Polymer Conjugates
por: Riool, Martijn, et al.
Publicado: (2022)

EDB-FN Targeted Peptide–Drug Conjugates for Use against Prostate Cancer
por: Park, Shang Eun, et al.
Publicado: (2019)

Multifunctional Peptide-Conjugated Hybrid Silica Nanoparticles for Photodynamic Therapy and MRI
por: Benachour, Hamanou, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a9okr5cgatjadu7iko5c63f64l